The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Unveiling the Catalytic Mechanism and Conformational Dynamics of Guinea Pig l -Asparaginase Type 1 for Leukemia Drug Design
Open accessPublished version of a preprint
Abstract
In this study, we present a computational analysis of the catalytic properties of guinea pig asparaginase type 1 (or gpASNase1), an enzyme of mammalian origin that offers a potential alternative for the treatment of acute lymphoblastic leukemia. This enzyme transforms asparagine into aspartate, depriving leukemia cells of this essential amino acid. A combination of molecular dynamics simulations, free energy calculations, and mechanistic insights based on quantum mechanics/molecular mechanics hybrid approaches was used to identify those residues contributing to the catalytic cycle of the enzyme. We dissected the contribution of enzymatic residues to substrate binding and selectivity, showing why this ASNase can degrade asparagine but not glutamine. We also studied the conformational dynamics of the enzymatic loop closing the active site, demonstrating that the substrate binding favors the closed state. The catalytic reaction mechanisms, composed of two stages, acylation and hydrolysis, were explored as well. The rate-limiting step presents a free energy barrier close to the experimental estimation and corresponds to the nucleophilic attack of enzymatic Thr19 on the carbonyl carbon atom of the substrate. Analysis of the electric field created by the protein sheds light on the role of certain residues and structural motifs in stabilizing the reaction transition state. The conclusions of this analysis are useful for rationalizing the properties of chimeras derived from gpASNase1 and predicting additional residue positions, where mutations could enhance substrate binding and loop dynamics. The results of this study enhance the understanding of gpASNase1, offering valuable insights into rational mutations and enzyme engineering for the treatment of leukemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures












Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
L-asparaginase in the treatment of patients with acute lymphoblastic leukemia
Egler, R. A., Ahuja, S. P., & Matloub, Y. (2016) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.184769 · Cited by 334
Research works printed but not linked: 49
- 10.1084/jem.118.1.99 · DOI
- 10.1146/annurev.biochem.75.103004.142520 · DOI
- 10.1007/s11274-019-2731-9 · DOI
- 10.1182/blood.V99.8.2734 · DOI
- 10.1007/s00280-017-3492-5 · DOI
- 10.1021/ja310165u · DOI
- 10.1021/acs.jcim.2c01122 · DOI
- 10.3390/pharmaceutics14030599 · DOI
- 10.1021/bi0029595 · DOI
- 10.1016/S0021-9258(18)62984-9 · DOI
- 10.1200/JCO.2001.19.9.2390 · DOI
- 10.1200/JCO.2012.43.2070 · DOI
- 10.1021/bi401692v · DOI
- 10.1021/bi300870g · DOI
- 10.1021/acs.jcim.3c00900 · DOI
- 10.1016/j.chembiol.2013.03.006 · DOI
- 10.1074/jbc.M113.545038 · DOI
- 10.1038/s41598-017-10758-4 · DOI
- 10.1074/jbc.M114.609552 · DOI
- 10.1074/jbc.M115.699884 · DOI
- 10.1021/acs.biochem.0c00116 · DOI
- 10.1182/blood-2013-10-535112 · DOI
- 10.1021/acs.biochem.5b01351 · DOI
- 10.1016/j.mehy.2018.01.004 · DOI
- 10.1021/ct100578z · DOI
- 10.1007/s00894-014-2478-z · DOI
- 10.1021/acs.jctc.5b00255 · DOI
- 10.1021/j100142a004 · DOI
- 10.1063/1.445869 · DOI
- 10.1002/jcc.540130805 · DOI
- 10.1063/1.464397 · DOI
- 10.1002/jcc.26873 · DOI
- 10.1021/acsomega.9b04233 · DOI
- 10.1021/acs.jpca.7b10842 · DOI
- 10.1038/s41467-024-46723-9 · DOI
- 10.1021/ct300418h · DOI
- 10.1016/S0022-2836(03)00610-7 · DOI
- 10.1021/bi400215w · DOI
- 10.1063/1.464913 · DOI · Paper page
- 10.1103/PhysRevB.37.785 · DOI · Paper page
- 10.1063/1.3382344 · DOI · Paper page
- 10.1021/acs.jctc.8b01176 · DOI
- 10.1021/ct100684s · DOI
- 10.1021/acs.jcim.1c00794 · DOI
- 10.1021/jz501780a · DOI
- Hanson K. R., 1972, The Enzymes, 7, 75
- 10.1021/acscatal.3c05302 · DOI
- 10.1101/2025.01.18.633707v1 · DOI
- 10.1182/blood-2014-03-563742 · DOI
Metadata
- Authors
- Andjelkovic, M., Zinovjev, K., Ruiz-Pernía, J. J., & Tuñón, I.
- Affiliations
- Universitat Jaume I (ES)
- Universitat de València (ES)
- Departamento de Química Física
- Corresponding author
- Tuñón, Iñaki
- Venue
- ACS Catalysis
- Publisher
- American Chemical Society (ACS)
- Published
- 2025-04-29
- Volume
- 15
- Issue
- 10
- Pages
- 7919-7933
- ISSN
- 2155-5435 (ISSN-L)
- PMC
- PMC12128190
- OpenAlex
- W4409921793
- Cited by
- 7
- References
- 2
- Citations by year
- 2026: 5 · 2025: 2
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- ACS Catalysis (publishedVersion, cc-by)
- ChemRxiv (acceptedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Repository of Digital Objects for Teaching Research and Culture (University of Valencia) (submittedVersion, cc-by-nc)
- Funders
- Ministerio de Ciencia, Innovaci?n y Universidades
- Agencia Estatal de Investigaci?n (PID2021-123332OB-C22)
- European Regional Development Fund
- 'la Caixa' Foundation (100010434, LCF/BQ/DR21/11880026)
- Conselleria de Cultura, Educaci?n y Ciencia, Generalitat Valenciana (CIPROM/2021/079)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Physical Sciences › Chemistry › Organic Chemistry › Physical Organic Chemistry and Reaction Kinetics
- Keywords
- catalytic mechanism, conformational dynamics, acute lymphoblastic leukemia, substrate binding, substrate specificity, acylation, hydrolysis, transition state stabilization, active site loop, enzyme engineering, chimeric enzymes, quantum mechanics/molecular mechanics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review